Innovating with Scott Amyx
Interview with Dr. Sungwon Lim CEO and Co-Founder of ImpriMed
ImpriMed uses artificial intelligence on live cancer cell analytics to predict how a patient will respond to cancer therapy drugs before taking them.
ImpriMed uses artificial intelligence on live cancer cell analytics to predict how a patient will respond to cancer therapy drugs before taking them.